Brown Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.89M | Buy |
34,155
+2,064
| +6% | +$112K | ﹤0.01% | 693 |
|
|
2025
Q4 | $1.57M | Sell |
32,091
-5,422
| -14% | -$253K | ﹤0.01% | 732 |
|
|
2025
Q3 | $1.62M | Buy |
37,513
+4,943
| +15% | +$193K | ﹤0.01% | 707 |
|
|
2025
Q2 | $1.25M | Buy |
32,570
+2,451
| +8% | +$93.7K | ﹤0.01% | 755 |
|
|
2025
Q1 | $1.17M | Sell |
30,119
-15,157
| -33% | -$555K | ﹤0.01% | 742 |
|
|
2024
Q4 | $1.53M | Buy |
45,276
+862
| +2% | +$31K | ﹤0.01% | 711 |
|
|
2024
Q3 | $1.82M | Buy |
44,414
+4,754
| +12% | +$194K | ﹤0.01% | 664 |
|
|
2024
Q2 | $1.53M | Sell |
39,660
-813
| -2% | -$34.2K | ﹤0.01% | 681 |
|
|
2024
Q1 | $1.74M | Buy |
40,473
+1,199
| +3% | +$49.4K | ﹤0.01% | 668 |
|
|
2023
Q4 | $1.46M | Sell |
39,274
-616
| -2% | -$22.1K | ﹤0.01% | 688 |
|
|
2023
Q3 | $1.45M | Sell |
39,890
-179
| -0.4% | -$6.35K | ﹤0.01% | 674 |
|
|
2023
Q2 | $1.43M | Sell |
40,069
-2,035
| -5% | -$73K | ﹤0.01% | 674 |
|
|
2023
Q1 | $1.5M | Buy |
42,104
+1,715
| +4% | +$60K | ﹤0.01% | 670 |
|
|
2022
Q4 | $1.42M | Sell |
40,389
-10,854
| -21% | -$362K | ﹤0.01% | 676 |
|
|
2022
Q3 | $1.51M | Buy |
51,243
+39,434
| +334% | +$1.49M | ﹤0.01% | 623 |
|
|
2022
Q2 | $643K | Buy |
11,809
+1,139
| +11% | +$62.9K | ﹤0.01% | 792 |
|
|
2022
Q1 | $581K | Sell |
10,670
-23,544
| -69% | -$1.28M | ﹤0.01% | 823 |
|
|
2021
Q4 | $1.89M | Buy |
34,214
+117
| +0.3% | +$6.09K | ﹤0.01% | 602 |
|
|
2021
Q3 | $1.63M | Buy |
34,097
+6,671
| +24% | +$335K | ﹤0.01% | 610 |
|
|
2021
Q2 | $1.36M | Sell |
27,426
-1,721
| -6% | -$82.7K | ﹤0.01% | 633 |
|
|
2021
Q1 | $1.3M | Sell |
29,147
-791
| -3% | -$35.9K | ﹤0.01% | 652 |
|
|
2020
Q4 | $1.38M | Sell |
29,938
-2,617
| -8% | -$120K | ﹤0.01% | 597 |
|
|
2020
Q3 | $1.53M | Buy |
32,555
+2,503
| +8% | +$125K | ﹤0.01% | 543 |
|
|
2020
Q2 | $1.53M | Buy |
30,052
+655
| +2% | +$33.6K | ﹤0.01% | 533 |
|
|
2020
Q1 | $1.39M | Sell |
29,397
-1,037
| -3% | -$55.3K | ﹤0.01% | 517 |
|
|
2019
Q4 | $1.79M | Sell |
30,434
-44
| -0.1% | -$2.45K | ﹤0.01% | 540 |
|
|
2019
Q3 | $1.63M | Buy |
30,478
+381
| +1% | +$19.6K | ﹤0.01% | 548 |
|
|
2019
Q2 | $1.5M | Sell |
30,097
-937
| -3% | -$47K | ﹤0.01% | 572 |
|
|
2019
Q1 | $1.62M | Sell |
31,034
-1,214
| -4% | -$60.7K | ﹤0.01% | 690 |
|
|
2018
Q4 | $1.54M | Sell |
32,248
-2,445
| -7% | -$120K | 0.01% | 646 |
|
|
2018
Q3 | $1.74M | Buy |
34,693
+2,668
| +8% | +$136K | 0.01% | 667 |
|
|
2018
Q2 | $1.61M | Sell |
32,025
-909
| -3% | -$45.8K | 0.01% | 672 |
|
|
2018
Q1 | $1.61M | Sell |
32,934
-40,476
| -55% | -$1.88M | 0.01% | 556 |
|
|
2017
Q4 | $3.25M | Sell |
73,410
-17,276
| -19% | -$798K | 0.01% | 461 |
|
|
2017
Q3 | $4.6M | Buy |
90,686
+12,093
| +15% | +$614K | 0.02% | 407 |
|
|
2017
Q2 | $4.24M | Sell |
78,593
-760
| -1% | -$40.5K | 0.01% | 428 |
|
|
2017
Q1 | $4.18M | Sell |
79,353
-1,311
| -2% | -$66.5K | 0.01% | 411 |
|
|
2016
Q4 | $3.88M | Sell |
80,664
-567
| -0.7% | -$28K | 0.01% | 415 |
|
|
2016
Q3 | $4.38M | Sell |
81,231
-1,085
| -1% | -$59.5K | 0.02% | 388 |
|
|
2016
Q2 | $4.46M | Sell |
82,316
-9,415
| -10% | -$496K | 0.02% | 376 |
|
|
2016
Q1 | $4.65M | Buy |
91,731
+41,362
| +82% | +$2.06M | 0.02% | 368 |
|
|
2015
Q4 | $2.54M | Buy |
50,369
+3,151
| +7% | +$161K | 0.01% | 448 |
|
|
2015
Q3 | $2.27M | Buy |
47,218
+8,153
| +21% | +$424K | 0.01% | 456 |
|
|
2015
Q2 | $2.03M | Sell |
39,065
-6,279
| -14% | -$354K | 0.01% | 449 |
|
|
2015
Q1 | $2.62M | Sell |
45,344
-8,295
| -15% | -$476K | 0.01% | 429 |
|
|
2014
Q4 | $2.87M | Sell |
53,639
-3,675
| -6% | -$206K | 0.01% | 416 |
|
|
2014
Q3 | $3.29M | Buy |
57,314
+673
| +1% | +$41.3K | 0.01% | 388 |
|
|
2014
Q2 | $3.79M | Sell |
56,641
-173
| -0.3% | -$11.7K | 0.01% | 368 |
|
|
2014
Q1 | $3.79M | Buy |
56,814
+415
| +0.7% | +$28.1K | 0.01% | 363 |
|
|
2013
Q4 | $3.76M | Buy |
56,399
+334
| +0.6% | +$21.7K | 0.01% | 353 |
|
|
2013
Q3 | $3.52M | Buy |
56,065
+2,560
| +5% | +$165K | 0.01% | 345 |
|
|
2013
Q2 | $3.34M | Buy |
+53,505
| New | +$3.4M | 0.01% | 342 |
|
Other funds holding GSK
JEST
Brown Advisory's GSK Position: Q1 2026 in Review
Brown Advisory increased its GSK (GSK) stake by 6.4% in Q1 2026, buying an estimated $112K and bringing the position to 34,155 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #693.
Brown Advisory first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.65M in Q1 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Brown Advisory held 34,155 shares of GSK worth $1.89M as of Q1 2026.
- Brown Advisory bought 2,064 GSK shares in Q1 2026, an estimated $112K.
- GSK made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #693 holding.
- Brown Advisory first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- Brown Advisory's GSK position peaked at $4.65M in Q1 2016.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.